1. Home
  2. SBR vs ABCL Comparison

SBR vs ABCL Comparison

Compare SBR & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBR
  • ABCL
  • Stock Information
  • Founded
  • SBR 1982
  • ABCL 2012
  • Country
  • SBR United States
  • ABCL Canada
  • Employees
  • SBR N/A
  • ABCL N/A
  • Industry
  • SBR Oil & Gas Production
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • SBR Energy
  • ABCL Health Care
  • Exchange
  • SBR Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • SBR 959.0M
  • ABCL 895.0M
  • IPO Year
  • SBR N/A
  • ABCL 2020
  • Fundamental
  • Price
  • SBR $62.90
  • ABCL $2.81
  • Analyst Decision
  • SBR
  • ABCL Buy
  • Analyst Count
  • SBR 0
  • ABCL 3
  • Target Price
  • SBR N/A
  • ABCL $8.50
  • AVG Volume (30 Days)
  • SBR 40.7K
  • ABCL 2.4M
  • Earning Date
  • SBR 01-01-0001
  • ABCL 11-04-2024
  • Dividend Yield
  • SBR 8.69%
  • ABCL N/A
  • EPS Growth
  • SBR 5.15
  • ABCL N/A
  • EPS
  • SBR 6.49
  • ABCL N/A
  • Revenue
  • SBR $97,974,633.00
  • ABCL $32,962,000.00
  • Revenue This Year
  • SBR N/A
  • ABCL N/A
  • Revenue Next Year
  • SBR N/A
  • ABCL $36.56
  • P/E Ratio
  • SBR $9.71
  • ABCL N/A
  • Revenue Growth
  • SBR 4.88
  • ABCL N/A
  • 52 Week Low
  • SBR $57.73
  • ABCL $2.34
  • 52 Week High
  • SBR $70.24
  • ABCL $6.06
  • Technical
  • Relative Strength Index (RSI)
  • SBR 44.48
  • ABCL 44.26
  • Support Level
  • SBR $61.50
  • ABCL $2.76
  • Resistance Level
  • SBR $66.96
  • ABCL $3.05
  • Average True Range (ATR)
  • SBR 1.34
  • ABCL 0.16
  • MACD
  • SBR -0.35
  • ABCL -0.03
  • Stochastic Oscillator
  • SBR 23.08
  • ABCL 0.00

About SBR Sabine Royalty Trust

Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma and Texas.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company have extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: